TRPV4 and heart failure: The first, study NCT02497937, aimed to assess the impact of the TRPV4 blocker GSK2798745 on pulmonary gas transfer and respiration in patients with congestive heart failure and the second trial, NCT02135861, sought to validate a novel treatment for pulmonary edema in cardiac failure.